FDA Inspection 1221183 - Astellas Pharma Inc. - October 27, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Astellas Pharma Inc., with an inspection on October 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Astellas Pharma Inc.
Inspection Date: October 27, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 7b2bb798-3d18-402e-a63a-d407730fcaa3

Violation Codes1

21 CFR 211.198(b)(2)

Full citation text and observation details available on the Dashboard.